Status:
COMPLETED
Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura
Lead Sponsor:
Juan Fernando Masa Jiménez
Conditions:
Coronavirus Disease 2019
Eligibility:
All Genders
Brief Summary
At the end of January 2020, the international community was informed of the presence of a new viral disease that started in Wuhan (China) and spread rapidly throughout the world. The identified virus ...
Detailed Description
Epidemiological, socio-sanitary, clinical, analytical and radiological data will be collected retrospectively and prospectively from all patients diagnosed with COVID-19 without hospital admission in ...
Eligibility Criteria
Inclusion
- Patients of any age and sex, including minors and pregnant women.
- Patients diagnosed with SARS-Cov2 infection according to the clinical and microbiological criteria established by the Health Authorities and clinical practice (these can be modified based on the Technical document "Clinical management of COVID-19" of the Ministry of Health) who require or not hospitalization and who receive or not specific pharmacologic treatment for the SARS-Cov2 infection.
Exclusion
- Patients who do not give their informed consent to participate in the study.
Key Trial Info
Start Date :
July 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT04724850
Start Date
July 14 2020
End Date
December 30 2022
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital San Pedro de Alcántara
Cáceres, Spain, 10600